Marion T. Kasaian

Pfizer (United States) — United States

Medicine · Health Sciences

35h-index3.5kcitations85works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(26), Immune Cell Function and Interaction(20), T-cell and B-cell Immunology(18), Monoclonal and Polyclonal Antibodies Research(17), IL-33, ST2, and ILC Pathways(15)

Publications85 total

Proteomic Differences in Colonic Epithelial Cells in Ulcerative Colitis Have an Epigenetic Basis
Gastro Hep Advances·2024· 3 citedOpen Access
A platform to reproducibly evaluate human colon permeability and damage
Scientific Reports·2023· 16 citedOpen Access
A platform to reproducibly evaluate human colon permeability and damage
Research Square (Research Square)·2023· 2 citedOpen Access
Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier
Inflammatory Bowel Diseases·2022· 52 citedOpen Access
Su1140: PROTEOMIC DIFFERENCES IN COLONIC EPITHELIAL CELLS IN ULCERATIVE COLITIS HAVE AN EPIGENETIC BASIS
Gastroenterology·2022
IL-13 Controls IL-33 Activity through Modulation of ST2
The Journal of Immunology·2021· 17 citedOpen Access
Sa137 A HIGH-THROUGHPUT MICROPHYSICOLOGIC SYSTEM ACCURATELY MODELS HUMAN COLON AND ILEUM FUNCTIONS
Gastroenterology·2021
Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease
Mucosal Immunology·2019· 44 citedOpen Access
The Progressive Multifocal Leukoencephalopathy Consortium as a Model for Advancing Research and Dialogue on Rare Severe Adverse Drug Reactions
Advances in Therapy·2019· 3 citedOpen Access
Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule Therapeutics
Drug Metabolism and Disposition·2018· 16 citedOpen Access
Proteomic analysis of serum and sputum analytes distinguishes controlled and poorly controlled asthmatics
Clinical & Experimental Allergy·2018· 29 cited
Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2
The Journal of Immunology·2018· 40 cited
Abrogation of IL-13Rα2 ameliorates acute inflammatory bowel disease
The Journal of Immunology·2017
IL-13Rα2 modulates inflammatory and metabolic effects of IL-33 by regulation of tissue IL-13 responses
The Journal of Immunology·2017
A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studies
mAbs·2016· 20 citedOpen Access
Effects of Ciclosporin A on Poly I:C-Induced Natural Killer Cell Activation and Interleukin-2 Transcription
2015
Expression of the IL-2 Receptor during Activation and Proliferation of Cytotoxic Effector Cells in vivo
2015
proliferation of human airway smooth muscle cells Tryptase and agonists of PAR-2 induce the
2015
Therapeutic activity of an interleukin‐4/interleukin‐13 dual antagonist on oxazolone‐induced colitis in mice
Immunology·2014· 49 citedOpen Access
Study on Effect of Head, Tail, and Limbud extracts of Mouse on Differentiation of Hair Follicle Stem Cells to Neural cells
SHILAP Revista de lepidopterología·2014Open Access
page 1 of 5Next →

Frequent Co-authors

Samuel J. Goldman(10), Paolo Casali(8), Lioudmila Tchistiakova(8), Debra D. Donaldson(6), Kimberly Marquette(6), T. Cook(6), Christine A. Biron(5), Agnes Brennan(5), Nancy Wood(4), Divya Chaudhary(4), Hideyuki Ikematsu(4), Cara Williams(4), Xin Xu(4), Karl Nocka(4), Bijia Deng(3), Mary Collins(3), Bruce A. Jacobson(3), Joseph P. Sypek(3), Alexander R. Margulis(3), Susan Fish(3)